St George’s, University of London research has found that a drug normally given to osteoporosis sufferers could provide effective pain relief to patients with knee and hip osteoarthritis.
Bisphosphonates are a group of drugs known to change the structure of bone and are most often prescribed to patients with osteoporosis, a condition characterised by fragile bones.
It is unknown, however, whether these drugs could be used to reduce pain and discomfort for patients with the joint condition osteoarthritis, which causes cartilage damage, bony growths and sore tissue.
The researchers used existing studies to assess the effectiveness of a variety of bisphosphonates in patients suffering from osteoarthritis of the hand, knee, spine and hips.
Of 3832 patients studied, in most cases these drugs showed limited pain relief. However, a few studies did show benefit; the bisphosphonate alendronate was found to be more effective for patients with hip osteoarthritis than existing pain relieving drugs. Moreover, the use of zoledronate and alendronate, specific forms of bisphosphonates, improved pain in patients with knee and hip osteoarthritis at six months —but longer term studies are needed.
Dr Nidhi Sofat, lead researcher, said: “Osteoarthritis is the most common form of arthritis worldwide. It causes damage to bone and cartilage in the joints of affected people. Most treatment is focused around pain relief, as no robust treatments have been discovered that slow down the progression of the disease.
“Our study looked at whether there were any bisphosphonate drugs that have been shown to influence pain and/or disease progression that could be used in osteoarthritis treatment.
“We found that, generally, bisphosphonates are ineffective at managing pain associated with osteoarthritis. But zoledronate and alendronate, which are specific forms of bisphosphonates, do show the potential for effective pain management specifically in patients with knee and hip osteoarthritis.
The Latest Bing News on:
Bisphosphonates
- Evidence-Based Treatment of Hypercalcemiaon April 24, 2024 at 5:00 pm
The authors used Ovid Medline to search for human trials on hypercalcemia and furosemide from 1950 to April 2008, and articles related to bisphosphonates and hypercalcemia during the same period.
- Bisphosphonates: How Long Is Enough?on April 23, 2024 at 5:00 pm
Bisphosphonates are the mainstay of osteoporosis therapy. Extensive clinical evaluation supports their utility in stemming progression of the disease and in reducing fracture risk. In the course ...
- Pregnancy-associated osteoporosis (PAO) – what is it and what are the symptomson April 17, 2024 at 4:31 am
“It is worth noting that another type of medication called ‘bisphosphonates’, which has traditionally been prescribed to help treat osteoporosis, is not recommended for pregnant women. “Although it ...
- This is why you must see a dentist about osteoporosis, according to our expert GPon April 17, 2024 at 1:13 am
Expert GP Dr Rosemary Leonard answers a reader's query about the reason they are being sent to a dentist following an osteoporosis diagnosis ...
- How Much Magnesium You Should Take in a Day, with an Expert Doctor’s Detailed Wisdomon April 16, 2024 at 12:36 pm
Magnesium is "the relaxation mineral," but many people are deficient. Experts reveal how much magnesium you need and the best ways to get it.
- Care Plan Your Doctor Would Usually Recommend For Kyphosison April 9, 2024 at 2:28 pm
Overview An abnormality of the spine causing excessive curvature of the upper back. This causes pain and stiffness. Symptoms It usually happens when osteoporosis badly weakens the spinal bones. It ...
- Bisphosphonates do not prevent ankylosis in a mouse model of spondyloarthritison May 7, 2020 at 4:28 pm
However, previous observations that pamidronate treatment reduces symptoms and bone edema in patients with spondyloarthritis suggest that different bisphosphonates could have different clinical ...
- Do bisphosphonates oversuppress bone turnover?on February 18, 2019 at 1:20 am
Bisphosphonates reduce fracture risk in postmenopausal women with osteoporosis, predominantly via their antiresorptive action on bone, but do they also suppress bone turnover to an extent that ...
- Bone-Building Medicationson March 25, 2016 at 12:33 pm
Estrogen, Evista, Fosteum, the bisphosphonates, and miacalcin all work in this way: Your bones have two types of cells that are always at work: osteoblasts which build bone and osteoclasts which break ...
- Drugs to treat osteoporosison September 20, 2013 at 1:59 pm
It's usually well tolerated, but as with all bisphosphonates, the "class" of drugs to which alendronate belongs, the most common side effects include diarrhea, nausea, vomiting, heartburn ...
The Latest Google Headlines on:
Bisphosphonates
[google_news title=”” keyword=”Bisphosphonates” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
The Latest Bing News on:
Osteoarthritis
- If detected early, osteoarthritis can be 'arrested' to restore joint healthon April 27, 2024 at 3:55 am
A team of researchers in the US predicted knee osteoarthritis via a blood test at least eight years before tell-tale signs of the disease appeared on.health. healthcare. fitness. wellness. well-being.
- Breakthrough blood test predicts osteoarthritis 8 years earlyon April 27, 2024 at 2:51 am
Blood test identifies knee osteoarthritis up to 8 years before X-ray detection. NEW YORK, April 27: Scientists have identified a potential breakthrough in the early detection of knee osteoarthritis, s ...
- Blood test predicts knee osteoarthritis eight years before tell-tale signs of the diseaseon April 26, 2024 at 10:53 pm
A blood test successfully predicted knee osteoarthritis at least eight years before tell-tale signs of the disease appeared on x-rays, Duke Health researchers report.
- Blood test may be able to detect osteoarthritis 8 years earlier than X-rayon April 26, 2024 at 12:00 pm
A blood test could help predict knee osteoarthritis at least eight years before the signs of the disease show up on X-rays, a new study indicates.
- Blood test powered by AI could catch osteoarthritis 8 years earlier than X-ray, early data showon April 26, 2024 at 11:00 am
A new blood test could determine whether someone will develop knee osteoarthritis up to eight years before structural damage is picked up by an X-ray.
- Blood test finds knee osteoarthritis up to 8 years before it appears on X-rayson April 26, 2024 at 11:00 am
Detecting knee osteoarthritis with a blood test up to eight years before it appears on X-rays -- as researchers have done -- could lead to therapies that delay disease progression and restore joint ...
- Blood Test Detects Knee Osteoarthritis 8 Years Before X-Rayson April 26, 2024 at 11:00 am
Early detection of knee osteoarthritis could lead to therapies that slow progression and restore joint health. A blood test successfully predicted knee osteoarthritis at least eight years before ...
- Rheumatoid Arthritis and Osteoarthritis patients genetically susceptible for developing COPD, suggests studyon April 26, 2024 at 8:00 am
Rheumatoid Arthritis and Osteoarthritis patients are genetically susceptible to developing COPD, suggests a study published in the Frontiers in Medicine.Observational studies have reported ...
- Self-administered acupressure reduces knee pain with suspected osteoarthritison April 24, 2024 at 12:31 pm
Self-administered acupressure (SAA) is an efficacious and cost-effective approach to relieve knee pain in middle-aged and older adults with probable knee osteoarthritis (OA), according to a study ...
- Semaglutide Improves Knee Osteoarthritis Pain, Physical Function in Phase 3 Trialon April 23, 2024 at 4:08 am
Results of the STEP 9 study in people with knee OA and obesity show that semaglutide not only induced significant weight loss but also improved knee pain and physical function.
The Latest Google Headlines on:
Osteoarthritis
[google_news title=”” keyword=”osteoarthritis” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]